Registered entities
Imaginab, Inc.
Reg. No. 264177873United States
Innovation
16 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 4,908 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 1 |
Social engagement
Social engagement: 6.6K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Norgine Ventures, Theravance Biopharma, Adage Capital Management, Novartis.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 21% |
| Private equity | 2 | 14% |
| Bank & private debt | 1 | 7% |
| Other / undisclosed | 8 | 57% |